Ambrx Biopharma Cayman, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $10M, a 15.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $10M -$1.82M -15.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $10.5M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $11M -$1.77M -13.9% Dec 31, 2022 10-Q 2023-08-09
Q2 2022 $11.9M Jun 30, 2022 6-K 2022-08-29
Q4 2021 $12.7M +$10.1M +382% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $2.64M Dec 31, 2020 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.